Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

NCT01574612 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Labialis

Interventions

DRUG: acyclovir/hydrocortisone cream

Sponsor

Meda Pharmaceuticals

Collaborators

[object Object]